Last edited by Fetaur
Tuesday, April 28, 2020 | History

4 edition of Aggregation of therapeutic proteins found in the catalog.

Aggregation of therapeutic proteins

  • 128 Want to read
  • 12 Currently reading

Published by Wiley in Hoboken, N.J .
Written in English

    Subjects:
  • Protein drugs,
  • Aggregation (Chemistry),
  • Recombinant Proteins -- therapeutic use,
  • Cell Aggregation,
  • Protein Conformation,
  • Protein Folding,
  • Recombinant Proteins -- metabolism

  • Edition Notes

    Includes bibliographical references.

    Statementedited by Wei Wang, Christopher J. Roberts.
    ContributionsWang, Wei, 1957 Mar. 10-, Roberts, Christopher John, 1972-
    Classifications
    LC ClassificationsRS431.P75 A34 2010
    The Physical Object
    Paginationp. ;
    ID Numbers
    Open LibraryOL24099207M
    ISBN 109780470411964
    LC Control Number2010008428


Share this book
You might also like
man remains

man remains

Long-term methanol vehicle test program

Long-term methanol vehicle test program

diary of William Hedges

diary of William Hedges

Rolls-Royce and Bentley

Rolls-Royce and Bentley

Two pictures; or, What we think of ourselves, and what the world thinks of us.

Two pictures; or, What we think of ourselves, and what the world thinks of us.

Logos, Doulos & Logus

Logos, Doulos & Logus

Mycorrhizae on Douglas fir and Ponderosa pine seedlings

Mycorrhizae on Douglas fir and Ponderosa pine seedlings

On-line information in public libraries

On-line information in public libraries

Lawyering from the heart

Lawyering from the heart

Presidential vetoes, 1989-1996

Presidential vetoes, 1989-1996

northeastern United States

northeastern United States

Baltimore, a picture history, 1858-1958, with a prologue.

Baltimore, a picture history, 1858-1958, with a prologue.

humanistic view of man

humanistic view of man

Oxfordshire minerals and waste local plan

Oxfordshire minerals and waste local plan

Choral and opera catalogue.

Choral and opera catalogue.

Worthy

Worthy

Aggregation of therapeutic proteins Download PDF EPUB FB2

Aggregation of Therapeutic Proteins and millions of other books are available for Amazon Kindle. Enter your mobile number or email address below and we'll send you a link to download the free Kindle App.

Then you can start reading Kindle books on your smartphone, tablet, or computer - 5/5(1). The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area.

This book fills such a need by providing an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins. Aggregation of Therapeutic Proteins | Wiley This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process.

aggregation has been mostly experimental. The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area. This book fills such a need by providing an.

Aggregation of Therapeutic Proteins summarizes current understanding and recent progress regarding protein aggregation in the context of biopharmaceutical products. The text: Explains methods to control or slow down the aggregation process—a major challenge for pharmaceutical and biotech companies Helps readers understand 5/5(1).

This book fills such a need by providing an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins. This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process.

Prevention or even moderate inhibition of protein aggregation has been mostly experimental. The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area.

Aggregation of Therapeutic Proteins provides an Aggregation of therapeutic proteins book resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process.

This book also covers an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins. The knowledge in this book will help pharmaceutical scientists in the development of therapeutic proteins.

Aggregation and Immunogenicity of Therapeutic Proteins Vasco Filipe Leiden/Amsterdam Center for Drug Research (LACDR), Division of Drug Delivery Technology, Biologics Formulation Group, Gorlaeus Laboratories, Leiden, The NetherlandsCited by: Protein Aggregation from the Unfolded State Aggregation Nucleation Multiplicity in Protein Aggregation Effects of Temperature Relationship between Temperature and Protein Stability Effect of High Temperature on Protein Aggregation Aggregation of therapeutic proteins book Temperature (m) and Protein T Aggregation   Aggregation of Therapeutic Proteins.

This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process. Aggregation of Therapeutic Proteins provides an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process.

This book also covers an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins. Prevention or even moderate inhibition of protein aggregation has been mostly experimental.

The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this : Wiley.

The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area. This book fills such a need by providing an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins.

Lee "Aggregation of Therapeutic Proteins" por disponible en Rakuten Kobo. This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and Brand: Wiley.

Mechanisms dictate formation rates and key characteristics of aggregates. Therapeutic proteins, such as MAbs, can form different types of aggregates (Figure 1). A folded MAb contains two identical Fab (antigen binding) regions or domains, and one Fc (conserved) region or by: Buy Aggregation of Therapeutic Proteins by Wei Wang, Christopher J.

Roberts (ISBN: ) from Amazon's Book Store. Everyday low prices and free delivery on eligible orders.5/5(1). PDF | On Jan 1,T. Arakawa and others published Aggregation analysis of therapeutic proteins, Part 2 | Find, read and cite all the research you need on ResearchGate.

Therapeutic proteins such as antibodies are playing an increasingly prominent role in the treatment of numerous diseases including cancer and rheumatoid arthritis. However, these proteins tend to degrade due to aggregation during manufacture and storage. Aggregation decreases protein activity and raises concerns about an immunological response.

We have recently developed a method based on full Cited by: One track focused on Protein Aggregation, Stability, and Solubility. The session chair’s introduction of Dr. Wei Wang (Pfizer, Groton, CT) referenced Aggregation of Therapeutic Proteins, 2 which he co-edited.

At the subsequent refreshment break, I looked through the book. Monoclonal antibodies (mAbs) are one of the most important class of therapeutic proteins. Their proteinaceous nature makes them labile towards aggregation, considered a critical quality attribute (CQA) as it affects safety and efficacy of a biotherapeutic : Rohit Bansal, Pulkit Srivastava, Anurag S.

Rathore, Paresh Chokshi. Aggregation of Therapeutic Proteins provides pharmaceutical scientists with a much-needed overview of the causes, consequences, characterization, and control of the aggregation of therapeutic proteins. protein aggregation. In part 1, we discuss general aspects of protein aggregation and present two techniques mentioned above: native gel electrophoresis and SEC.

MECHANISMS OF AGGREGATION Mechanisms of protein aggregation are still not fully understood, despite the fact that aggregation is a major problem in therapeutic-protein development. Protein aggregation is one of the most common routes for protein instability, and in therapeutic protein production can render the product unfit for release [19].

Immunogenicity of therapeutic proteins: Influence of aggregation Article Literature Review (PDF Available) in Journal of Immunotoxicology 11(2) August with 1, Reads.

Many therapeutic proteins are required in high doses, administered as part of frequent-dosing regimens, which means that it is important to keep them stably dissolved for extended periods of Cited by: The kinetics of protein aggregation has been extensively investigated.

Lumry and Eyring () polymerization model has been used as a starting point to study protein aggregation. In the type of situation described by a Lumry– Eyring model(Sa´nchez-Ruiz, ),the thermodynamically stable protein with respect to unfolded and partially.

Scientists are using fluid imaging devices, which use an optical system similar to a microscope, to capture detailed pictures of particles that are formed when therapeutic proteins and chemicals used in syringe production interact, which can lead to protein aggregation.

Monoclonal antibodies (mAbs) are the fastest-growing biological therapeutics with important applications ranging from cancers, autoimmunity diseases and metabolic disorders to emerging infectious diseases. Aggregation of mAbs continues to be a major problem in their developability.

Antibody aggregation could be triggered by partial unfolding of its domains, leading to monomer-monomer Cited by: Fully updated and practical, Therapeutic Proteins: Methods and Protocols, Second Edition provides an essential resource to all scientists working in the field of therapeutic proteins.

Keywords Bioinformatics Drug discovery Pharmaceutical design Protein drug production Protein therapeutics Therapeutic protein development. For therapeutic proteins, aggregates are a significant risk factor for deleterious immune responses in patients, and can form via a variety of mechanisms.

Controlling aggregation using a mechanistic approach may allow improved design of therapeutic protein stability, as a complement to existing design strategies that target desired protein Cited by: aggregation-prone regions (APR), drive protein aggregation.

Computational tools have been developed for the identification of APRs on proteins, but very few of them have been validated on antibody molecules Sequence-based computational tools such as TANGO and PAGE,12,13 and structure-based tool such.

The text points to the criticality of minimizing protein aggregation in therapeutic products and the need to develop minimization strategies as early as is feasible in product development. It states that, ‘methods that individually or in combination enhance detection of protein aggregates should be employed to characterize distinct species of.

Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding of the roles of aggregates in immunogenicity of therapeutic protein products is critical. Such immune responses can.

Protein aggregation is a biological phenomenon in which mis-folded proteins aggregate (i.e., accumulate and clump together) either intra- or extracellularly. These protein aggregates are often correlated with diseases.

In fact, protein aggregates have been implicated in a wide variety of disease known as amyloidoses, including ALS, Alzheimer's, Parkinson's and prion disease.

After synthesis. Immunogenicity of therapeutic proteins: Influence of aggregation Kirsty D. Ratanji, Jeremy P.

Derrick, Rebecca J. Dearman, and Ian Kimber Faculty of Life Sciences, University of Manchester, Manchester, UK Abstract The elicitation of anti-drug antibodies (ADA) against biotherapeutics can have detrimental.

Protein aggregation trends in neurodegenerative diseases are largely unmapped due to the complex nature of protein-protein interactions and their regulatory machineries such as protein proteolytic systems. Since the protein aggregation process in humans is a slow process, early determination of the patients that will develop neurodegenerative diseases later in life is critical in terms of Cited by: 1.

ARTICLE Determination of Protein Aggregation With Differential Mobility Analysis: Application to IgG Antibody Leonard F.

Pease III,1 John T. Elliott,1 De-Hao Tsai,1 Michael R. Zachariah,1,2 Michael J. Tarlov1 1National Institute of Standards and Technology (NIST), Bureau Drive MSGaithersburg, Maryland ; telephone: (M.J.T.)/ (M.R.Z.);File Size: KB.

o Immunogenicity of therapeutic protein aggregates o Clinical evidence 3 Felipe et al. Aggregation of Therapeutic Proteins. Clinical evidence 4 Moussa et al.

J Pharm Sci. Human gamma globulin Human growth hormone Recombinant human erythropoietin Interferons. Monoclonal antibodies (mAbs) are the fastest growing class of drugs in the pharmaceutical industry. However, they can be plagued by long term stability issues, including aggregation and phase separation, that have yet to be fully understood.

We have demonstrated an approach to characterize protein unfolding and aggregation and provide insight into destabilization mechanisms. Therapeutic protein products (TPP) have been widely used to treat a variety of human diseases, including cancer, hemophilia, and autoimmune diseases.

However, TPP can induce unwanted immune responses that can impact both drug efficacy and patient safety. The presence of aggregates is of particular concern as they have been implicated in inducing both T cell-independent and T cell Cited by: THIS IS ADIGITAL BOOK: AVAILABLE IN PDF VERSION.

THIS IS ADIGITAL BOOK: AVAILABLE IN PDF VERSION. Skip to main content. Shop by category. Shop by category. Enter your search keyword Aggregation of Therapeutic Proteins by Wei Wang & Christopher J. Roberts; VG++. $ + $ Shipping. Aggregation of Therapeutic Proteins by Wei Wang Seller Rating: % positive.PROTEIN AGGREGATION AND CELL CULTURE.

PROTEIN AGGREGATION AND PURIFICATION. SUMMARY. CHAPTER 7 Protein Aggregation and Particle Formation: Effects of Formulation, Interfaces, and Drug Product Manufacturing Operations.

INTRODUCTION. ROLES OF CONFORMATIONAL AND COLLOIDAL STABILITY IN REDUCING RATES OF AGGREGATION. .